MARKET

MBQIF

MBQIF

Mindbio Therapeutics Corp
OTCMQB
0.700
NaN%
Closed 09:30 05/15 EDT
OPEN
--
PREV CLOSE
0.780
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.020
52 WEEK LOW
0.600
MARKET CAP
5.10M
P/E (TTM)
-0.1740
1D
5D
1M
3M
1Y
5Y
1D
IBN ANNOUNCES LATEST EPISODE OF THE TECHMEDIAWIRE PODCAST FEATURING JUSTIN HANKA, CEO OF MINDBIO THERAPEUTICS CORP.
Reuters · 4d ago
MindBio develops AI voice model to predict fatigue, adds module to detection kiosks
PUBT · 5d ago
Weekly Report: what happened at MBQIF last week (0504-0508)?
Weekly Report · 5d ago
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
Barchart · 5d ago
MindBio develops cross-language AI speech model detecting drug, alcohol intoxication
PUBT · 05/05 13:31
MindBio Develops Cross-Language AI Speech Analytics Capability for Intoxication Detection Patent applications filed in 15 world firsts using Voice and AI
Barchart · 05/05 08:31
Weekly Report: what happened at MBQIF last week (0427-0501)?
Weekly Report · 05/04 10:43
MindBio says voice AI model predicts drug, alcohol intoxication using 50 million data points
PUBT · 04/29 11:21
More
About MBQIF
MindBio Therapeutics Corp. is a clinical-stage biopharmaceutical company. It creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. It is focused on microdosing of psychedelic medicines and is advancing its drug and technology through clinical trials. It develops a multidisciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase I clinical trials in 80 healthy participants and has completed Phase II clinical trials in patients with Major Depressive Disorder. Underway are Phase IIB trials, one in cancer patients experiencing existential distress and another in patients with Major Depressive Disorder. It invests in research that forms the basis for developing novel and clinically proven treatments.

Webull offers MindBio Therapeutics Corp stock information, including OTCMQB: MBQIF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBQIF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBQIF stock methods without spending real money on the virtual paper trading platform.